Table 2

Correlation of changes in liver fat with changes in other parameters, adjusted for sex and intervention group

Absolute Δ liver fatP valuePercent Δ liver fatP value
Measures of adiposity
    Δ weight0.2310.0300.3490.001
    Δ waist0.0220.8350.1160.281
    Δ BMI0.1940.0700.2590.015
    Δ total fat0.0950.3780.0970.367
    Δ subcutaneous fat0.1350.2090.1110.304
    Δ intraperitoneal fat0.0560.6040.0450.676
    Δ retroperitoneal fat0.0800.4560.1450.179
Metabolic parameters
    Δ A1C0.3110.0040.419<0.0001
    Δ glucose0.2910.0070.3730.001
    Δ insulin*−0.1860.137−0.3020.015
    Δ total cholesterol0.0500.6540.0420.701
    Δ HDL0.0720.5170.0050.964
    Δ triglycerides0.1870.0890.3360.002
    Δ LDL−0.0840.447−0.1050.342
    Δ HDL-to-triglyceride ratio0.1280.2460.2760.011
Liver tests
    Δ ALT0.2940.0050.2110.047
    Δ AST0.3480.0010.2800.008
    Δ GGT0.2770.0090.2870.006
    Δ AST-to-ALT ratio−0.0300.781−0.0330.762
Inflammatory markers
    Δ IL-80.0140.904−0.0850.466
    Δ IL-100.1360.245−0.0100.934
    Δ TNF-α−0.0240.840−0.0020.986
    Δ adiponectin0.0620.600−0.1240.290
    Δ ghrelin0.1950.0940.2140.065
    Δ resistin−0.1220.297−0.0790.498
  • *Among non–insulin users.